• Tobias Magid, Nicolai Haase, Jakob Steen Andersen, Ove Juul Nielsen, and Jan Bonde.
• Intensive Care Unit, 4131, Rigshospitalet, København, Denmark. tobias@dadlnet.dk
• Dan Med J. 2012 Mar 1;59(3):A4395.

IntroductionThis article presents the treatment results of 320 consecutive patients with malignant haematological diagnoses admitted to a tertiary intensive care unit at a Danish University hospital over a six-year period (2005-2010). With reference to international publications, we describe the development in treatment.Material And MethodsThis was a retrospective observational study.ResultsThe median age was 59 years. The median intensive care unit (ICU) stay was six days. A total of 88% required mechanical ventilation, and 72% received vasopressor treatment. The median Simplified Acute Physiology Score II score was 58. The ICU and one-year mortality rates were 44% and 77%, respectively, but mortality was significantly lower for patients aged 0-20 years. For patients aged 20-80 years, the mortality risk was independent of age. For the group of patients admitted acutely to the ICU with other diagnoses, the ICU- and the one-year mortality rate was 13% and 33%, respectively.ConclusionDespite progress, the mortality rate for haematological patients in ICUs is high. We lack valid tools that allow us to differentiate between those who can benefit from intensive care and those for whom transfer to an ICU is futile. One patient out of five is alive after one year. This supports a strategy offering haematological patients intensive care on an equal footing with other patients. Follow-up studies of survivors, clarification of function level and quality of life are needed.Fundingnot relevant.Trial Registrationnot relevant.

30 keywords...

hide…